EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation and Mitigation of Time‐Dependent Confounding Effects in Conventional Exposure‐Response Analyses for Oncology Drugs

Xuefen Yin iD, Ye Xiong iD, Youwei Bi, Xin Wei iD, Hong Zhao, Elimika Pfuma Fletcher iD, Rajanikanth Madabushi, Amal Ayyoub, Hao Zhu, Stephan Schmidt iD, Jiang Liu iD

CPT: Pharmacometrics & Systems Pharmacology · 2025-12 · 14 (12) · 2118-2127

DOI: 10.1002/psp4.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 25.09.2025. Verfasst von Xuefen Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Office of Women's Health, FDA, Office of Women's Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional exposure–response (E–R) analyses, such as logistic regression and time‐to‐event analysis using summary exposure metrics, are often conducted in oncology using data from the pivotal trial(s) with a single dose level to support dosing decisions. However, these E–R analyses, affected by multiple confounding factors, may mischaracterize true E–R relationships, potentially limiting their utility in dosing decisions. This study investigates potential mischaracterization in such analyses influenced by the following time‐dependent confounding factors: exposure accumulation, dose modification patterns, and event onset time. We used a simulation‐based approach to evaluate two E–R scenarios: ER1, where event time generated with a Weibull distribution is not affected by drug exposure, and ER2, where the response is driven by drug exposure via a joint PK‐tumor size model. Our analyses indicate that when using time‐dependent exposure metrics (e.g., average concentration till event/censoring), exposure accumulation tends to induce an inverse E–R trend, while dose modifications (interruptions/reductions) likely induce a positive E–R trend. Simulations suggest that employing static exposure metrics (e.g., first‐cycle or steady‐state) minimizes these biases. Additionally, adopting an E max model aligned with the underground truth in ER2 in the E–R analyses could reduce bias. When significant dose modifications are present, including relevant data from a dose‐range study and employing modified methods for time‐dependent exposure derivation may help mitigate bias. Overall, using multiple exposure metrics (including static ones) to assess E–R consistency and interpreting the potential causal effects with totality of evidence (including dose–response results) should be implemented to better inform dosing decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansDose-Response Relationship, DrugComputer SimulationTime FactorsModels, BiologicalConfounding Factors, Epidemiologic

Stichwörter der Autor:innen

PK accumulationbias controldose modificationexposure–responseoncology dosingtime‐dependent confounding factors

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Xuefen Yin, Ye Xiong, Xin Wei, Elimika Pfuma Fletcher, Stephan Schmidt, Jiang Liu

Förderung

  • Office of Women's Health, FDA
  • Office of Women's Health

Zitieren

APA

Yin, X., Xiong, Y., Bi, Y., Wei, X., Zhao, H., Fletcher, E. P., Madabushi, R., Ayyoub, A., Zhu, H., Schmidt, S., & Liu, J. (2025). Evaluation and Mitigation of Time‐Dependent Confounding Effects in Conventional Exposure‐Response Analyses for Oncology Drugs. CPT: Pharmacometrics & Systems Pharmacology, 14(12), 2118-2127. https://doi.org/10.1002/psp4.70119

Vancouver

Yin X, Xiong Y, Bi Y, Wei X, Zhao H, Fletcher EP, et al. Evaluation and Mitigation of Time‐Dependent Confounding Effects in Conventional Exposure‐Response Analyses for Oncology Drugs. CPT: Pharmacometrics & Systems Pharmacology. 2025;14(12):2118-2127. doi:10.1002/psp4.70119

BibTeX
@article{Yin2025,
  author = {Yin, Xuefen and Xiong, Ye and Bi, Youwei and Wei, Xin and Zhao, Hong and Fletcher, Elimika Pfuma and Madabushi, Rajanikanth and Ayyoub, Amal and Zhu, Hao and Schmidt, Stephan and Liu, Jiang},
  title = {Evaluation and Mitigation of Time‐Dependent Confounding Effects in Conventional Exposure‐Response Analyses for Oncology Drugs},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {2118--2127},
  doi = {10.1002/psp4.70119}
}
Kostenlos starten →